Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112369204 | 11236920 | 4 | F | 2011 | 20160906 | 20150703 | 20160914 | EXP | US-DSJP-DSU-2015-120154 | DAIICHI | 0.00 | Y | 0.00000 | 20160913 | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112369204 | 11236920 | 1 | PS | BENICAR | OLMESARTAN MEDOXOMIL | 1 | Oral | 40 MG, QD | N | 21286 | 40 | MG | TABLET | QD | |||||
| 112369204 | 11236920 | 2 | SS | BENICAR | OLMESARTAN MEDOXOMIL | 1 | 40 MG, QD | N | 21286 | 40 | MG | TABLET | QD | ||||||
| 112369204 | 11236920 | 3 | SS | BENICAR HCT | HYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | Oral | 20/12.5 MG, QD | N | 0 | 1 | DF | FILM-COATED TABLET | QD | |||||
| 112369204 | 11236920 | 4 | SS | BENICAR HCT | HYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | Oral | 20/12.5 MG, QD | N | 0 | 1 | DF | FILM-COATED TABLET | QD | |||||
| 112369204 | 11236920 | 5 | SS | BENICAR HCT | HYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | Oral | 20/12.5 MG 0.5 TABLET, QD | N | 0 | 1 | DF | FILM-COATED TABLET | QD | |||||
| 112369204 | 11236920 | 6 | C | LASIX | FUROSEMIDE | 1 | UNK, PRN | 0 | |||||||||||
| 112369204 | 11236920 | 7 | C | XANAX | ALPRAZOLAM | 1 | Oral | 1 MG, TID | 0 | 1 | MG | TABLET | TID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 112369204 | 11236920 | 1 | Hypertension |
| 112369204 | 11236920 | 3 | Hypertension |
| 112369204 | 11236920 | 6 | Product used for unknown indication |
| 112369204 | 11236920 | 7 | Anxiety |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 112369204 | 11236920 | HO |
| 112369204 | 11236920 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 112369204 | 11236920 | Acute kidney injury | |
| 112369204 | 11236920 | Drug prescribing error | |
| 112369204 | 11236920 | Gastric mucosa erythema | |
| 112369204 | 11236920 | Gastric polyps | |
| 112369204 | 11236920 | Gastrointestinal melanosis | |
| 112369204 | 11236920 | Gastrooesophageal reflux disease | |
| 112369204 | 11236920 | Hepatic steatosis | |
| 112369204 | 11236920 | Hiatus hernia | |
| 112369204 | 11236920 | Irritable bowel syndrome | |
| 112369204 | 11236920 | Malabsorption |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 112369204 | 11236920 | 1 | 201304 | 0 | ||
| 112369204 | 11236920 | 2 | 20140115 | 2014 | 0 | |
| 112369204 | 11236920 | 3 | 200803 | 201304 | 0 | |
| 112369204 | 11236920 | 4 | 20140115 | 0 | ||
| 112369204 | 11236920 | 7 | 2008 | 2014 | 0 |